Akanda (NASDAQ:AKAN) Announces Quarterly Earnings Results

Akanda (NASDAQ:AKAN) issued its earnings results on Wednesday. The company reported ($5.90) EPS for the quarter, FiscalAI reports. The firm had revenue of $0.20 million for the quarter.

Akanda Stock Performance

Akanda stock traded down $0.36 during midday trading on Thursday, reaching $2.21. The company’s stock had a trading volume of 236,559 shares, compared to its average volume of 1,325,394. Akanda has a 52 week low of $2.20 and a 52 week high of $78.90. The business has a 50-day moving average price of $4.29 and a 200-day moving average price of $9.99.

Analyst Ratings Changes

AKAN has been the topic of several analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Akanda in a research report on Thursday, August 13th. Wall Street Zen downgraded shares of Akanda from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

About Akanda

Akanda Corporation is an international medical cannabis company focused on the cultivation, processing, distribution and sale of cannabis products. Its activities have included medical cannabis flower, oils and other formulations intended for patients and healthcare markets.

The company has historically operated through businesses serving the European medical cannabis industry. Its operations have included cultivation and processing activities in Portugal, as well as CanMart, a United Kingdom-based importer and distributor of pharmaceutical-grade medical cannabis products.